Faron, etusivu

releases and publications

MATINS Trial in Cell Reports Medicine

Grant of options

Insider Transaction Regulatory

Faron Initiates Phase 2 Part of BEXMAB Study

Regulatory

Faron to present data from BEXMAB study at ASH

Regulatory

Managers’ transactions

Insider Transaction Regulatory

Exercise of options

Insider Transaction Regulatory

Results of Placing

Regulatory

Proposed Issue and Placing

Regulatory

Faron Announces Positive BEXMAB Study Update

Regulatory

Faron to host webcast on new BEXMAB study data

PreviousNext
Back to top